Skip to search formSkip to main contentSkip to account menu

Molecular Target

Every point of difference between premalignant or malignant cells and their normal counterparts is a potential target of opportunity for drug… 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2017
2017
MiR-876-5p suppresses epithelial–mesenchymal transition of lung cancer by directly down-regulating bone morphogenetic protein 4
Lung cancer is the leading cause of cancer-related death throughout the world. We aimed to investigate the role of a novel… 
2017
2017
Functional analysis of Discoidin domain receptor 2 mutation and expression in squamous cell lung cancer.
2011
2011
Clinical value of signal transducers and activators of transcription 3 (STAT3) gene expression in human osteosarcoma.
2010
2010
Requirement of T-lymphokine-activated killer cell-originated protein kinase for TRAIL resistance of human HeLa cervical cancer cells.
2010
2010
MicroRNA-21 Overexpression Contributes to Vestibular Schwannoma Cell Proliferation and Survival
Hypothesis: Elevated levels of hsa-microRNA-21 (miR-21) in vestibular schwannomas (VSs) may contribute to tumor growth by… 
Highly Cited
2007
Highly Cited
2007
Genome-wide exploration of the drug action of capreomycin on Mycobacterium tuberculosis using Affymetrix oligonucleotide GeneChips.
2006
2006
Down-regulation of CT120A by RNA interference suppresses lung cancer cells growth and sensitizes to ultraviolet-induced apoptosis.
2005
2005
Requirement of the extracellular cysteine at position six for CD40/CD40 dimer formation and CD40-induced IL-8 expression.
Review
2004
Review
2004
COX-2: a target for prevention and treatment of esophageal cancer.
Review
2003
Review
2003
The folate receptor as a molecular target for tumor-selective radionuclide delivery.
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)